Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis

Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis

Abstract Background Pneumatosis intestinalis (PI) is a rare complication of chemotherapy, characterized by multiple gas accumulations within the bowel wall. Case presentation A 71-year-old woman with epidermal growth factor receptor (EGFR) mutation-positive lung adenocarcinoma was admitted to our ho...

Full description

Bibliographic Details
Main Authors: Hironori Uruga, Shuhei Moriguchi, Yui Takahashi, Kazumasa Ogawa, Kyoko Murase, Sayaka Mochizuki, Shigeo Hanada, Hisashi Takaya, Atsushi Miyamoto, Nasa Morokawa, Kazuma Kishi
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Cancer
Subjects:
Pneumatosis intestinalis
Epidermal growth factor receptor tyrosine kinase inhibitor
Leptomeningeal carcinomatosis
Non-small-cell lung cancer
Online Access:http://link.springer.com/article/10.1186/s12885-018-4743-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4743-5

Similar Items